Brookstone Capital Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $35.2M | Buy |
97,295
+20,957
| +27% | +$7.17M | 0.35% | 70 |
|
|
2026
Q1 | $26.9M | Buy |
76,338
+1,929
| +3% | +$688K | 0.31% | 88 |
|
|
2025
Q4 | $24.4M | Buy |
74,409
+3,098
| +4% | +$983K | 0.28% | 91 |
|
|
2025
Q3 | $20.1M | Buy |
71,311
+16,042
| +29% | +$4.65M | 0.24% | 103 |
|
|
2025
Q2 | $15.4M | Buy |
55,269
+5,517
| +11% | +$1.56M | 0.2% | 117 |
|
|
2025
Q1 | $15.5M | Buy |
49,752
+30,500
| +158% | +$9.01M | 0.22% | 111 |
|
|
2024
Q4 | $5.02M | Buy |
19,252
+1,462
| +8% | +$434K | 0.07% | 250 |
|
|
2024
Q3 | $5.73M | Buy |
17,790
+1,214
| +7% | +$397K | 0.08% | 229 |
|
|
2024
Q2 | $5.56M | Buy |
16,576
+8,350
| +102% | +$2.45M | 0.09% | 212 |
|
|
2024
Q1 | $2.34M | Sell |
8,226
-45,873
| -85% | -$13.4M | 0.04% | 332 |
|
|
2023
Q4 | $15.6M | Sell |
54,099
-6,101
| -10% | -$1.66M | 0.3% | 83 |
|
|
2023
Q3 | $16.9M | Sell |
60,200
-8,331
| -12% | -$2.08M | 0.37% | 71 |
|
|
2023
Q2 | $15M | Buy |
68,531
+3,725
| +6% | +$864K | 0.3% | 92 |
|
|
2023
Q1 | $16.1M | Buy |
64,806
+57,482
| +785% | +$14.1M | 0.31% | 88 |
|
|
2022
Q4 | $2.02M | Sell |
7,324
-40,089
| -85% | -$10.7M | 0.04% | 312 |
|
|
2022
Q3 | $11.7M | Buy |
47,413
+3,375
| +8% | +$818K | 0.27% | 93 |
|
|
2022
Q2 | $10.9M | Buy |
44,038
+12,570
| +40% | +$3.08M | 0.24% | 101 |
|
|
2022
Q1 | $7.89M | Buy |
31,468
+4,531
| +17% | +$1.04M | 0.15% | 136 |
|
|
2021
Q4 | $6.12M | Buy |
26,937
+20,659
| +329% | +$4.36M | 0.11% | 159 |
|
|
2021
Q3 | $1.28M | Sell |
6,278
-1,563
| -20% | -$360K | 0.02% | 340 |
|
|
2021
Q2 | $1.92M | Buy |
7,841
+3,112
| +66% | +$766K | 0.03% | 267 |
|
|
2021
Q1 | $1.18M | Sell |
4,729
-483
| -9% | -$115K | 0.05% | 235 |
|
|
2020
Q4 | $1.2M | Sell |
5,212
-499
| -9% | -$115K | 0.05% | 215 |
|
|
2020
Q3 | $1.45M | Buy |
5,711
+1,356
| +31% | +$336K | 0.07% | 179 |
|
|
2020
Q2 | $1.03M | Sell |
4,355
-2,465
| -36% | -$562K | 0.06% | 168 |
|
|
2020
Q1 | $1.38M | Sell |
6,820
-2,391
| -26% | -$522K | 0.08% | 142 |
|
|
2019
Q4 | $2.22M | Sell |
9,211
-1,628
| -15% | -$359K | 0.11% | 114 |
|
|
2019
Q3 | $2.1M | Sell |
10,839
-2,873
| -21% | -$551K | 0.11% | 117 |
|
|
2019
Q2 | $2.53M | Buy |
13,712
+11,262
| +460% | +$2.02M | 0.15% | 118 |
|
|
2019
Q1 | $466K | Sell |
2,450
-998
| -29% | -$191K | 0.03% | 256 |
|
|
2018
Q4 | $671K | Sell |
3,448
-4,499
| -57% | -$878K | 0.05% | 156 |
|
|
2018
Q3 | $1.65M | Sell |
7,947
-108
| -1% | -$21.3K | 0.13% | 141 |
|
|
2018
Q2 | $1.49M | Buy |
8,055
+3,823
| +90% | +$676K | 0.13% | 133 |
|
|
2018
Q1 | $721K | Buy |
4,232
+373
| +10% | +$68.5K | 0.07% | 154 |
|
|
2017
Q4 | $671K | Sell |
3,859
-336
| -8% | -$59.5K | 0.06% | 168 |
|
|
2017
Q3 | $782K | Sell |
4,195
-364
| -8% | -$64.5K | 0.07% | 161 |
|
|
2017
Q2 | $785K | Buy |
4,559
+61
| +1% | +$9.92K | 0.07% | 154 |
|
|
2017
Q1 | $738K | Buy |
+4,498
| New | +$747K | 0.07% | 148 |
|
|
2015
Q4 | – | Sell |
-203
| Closed | -$28K | – | 191 |
|
|
2015
Q3 | $28K | Sell |
203
-286
| -58% | -$45.1K | 0.01% | 613 |
|
|
2015
Q2 | $75K | Buy |
+489
| New | +$78.3K | 0.01% | 388 |
|
Other funds holding AMGN
FFM
SP
Brookstone Capital Management's AMGN Position: Q2 2026 in Review
Brookstone Capital Management increased its Amgen (AMGN) stake by 27% in Q2 2026, buying an estimated $7.17M and bringing the position to 97,295 shares worth $35.2M. The position accounts for 0.35% of the portfolio, ranked #70.
Brookstone Capital Management first reported a position in AMGN in Q2 2015 and has held it in 40 quarters since. 1,228 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Brookstone Capital Management held 97,295 shares of Amgen worth $35.2M as of Q2 2026.
- Brookstone Capital Management bought 20,957 Amgen shares in Q2 2026, an estimated $7.17M.
- Amgen made up 0.35% of Brookstone Capital Management's portfolio in Q2 2026, its #70 holding.
- Brookstone Capital Management first reported a position in Amgen in Q2 2015 and has held it in 40 quarters since.
- 1,228 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Brookstone Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.